GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » Debt-to-Revenue

PreveCeutical Medical (XCNQ:PREV) Debt-to-Revenue : N/A (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PreveCeutical Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$3.78 Mil. PreveCeutical Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was C$0.00 Mil. PreveCeutical Medical's annualized Revenue for the quarter that ended in Sep. 2023 was C$0.00 Mil.


PreveCeutical Medical Debt-to-Revenue Historical Data

The historical data trend for PreveCeutical Medical's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical Debt-to-Revenue Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Revenue
Get a 7-Day Free Trial 243.47 1,583.33 N/A N/A N/A

PreveCeutical Medical Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of PreveCeutical Medical's Debt-to-Revenue

For the Biotechnology subindustry, PreveCeutical Medical's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's Debt-to-Revenue falls into.



PreveCeutical Medical Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PreveCeutical Medical's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.292 + 0) / N/A
=N/A

PreveCeutical Medical's annualized Debt-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2023) Revenue data.


PreveCeutical Medical Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical (XCNQ:PREV) Business Description

Traded in Other Exchanges
Address
885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines